Clinical Research Directory
Browse clinical research sites, groups, and studies.
AAV8-hCocH for Cocaine Use Disorder
Sponsor: W. Michael Hooten
Summary
The purpose of this study is to test the safety of a novel gene viral vector treatment for adults with cocaine use disorder-sustained remission. This gene regulates an enzyme (cocaine hydrolase) that breaks down cocaine into inactive substances, thereby decreasing the pleasurable feeling this drug usually provides.
Official title: Intravenous Administration of AAV8-human Cocaine Hydrolase to Treat Cocaine Use Disorder
Key Details
Gender
All
Age Range
18 Years - 65 Years
Study Type
INTERVENTIONAL
Enrollment
10
Start Date
2021-10-08
Completion Date
2026-12
Last Updated
2026-03-27
Healthy Volunteers
Yes
Conditions
Interventions
AAV8-hCocH
2e12 vg/kg single infusion intravenous
AAV8-hCocH
6e12 vg/kg single infusion intravenous
AAV8-hCocH
4e12 vg/kg single infusion intravenous
Locations (1)
Mayo Clinic in Rochester
Rochester, Minnesota, United States